Paul Steven M (CIK 0001237564)

Latest company ownership

Shares held
41,666
Last filed at
Sep 15, 2025
Confidence Score
59.4
2025Q4
Confidence Score History
2025Q3 2025Q4
Shares held
15,000
Last filed at
Apr 5, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q1 2025Q4
Shares held
15,000
Last filed at
Jun 4, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2016Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 12, 2025 Sep 15, 2025 Rapport Therapeutics, Inc. Director Buy 100.0 +41,666 100.00% ✗ $1M
Apr 1, 2022 Apr 5, 2022 ALNYLAM PHARMACEUTICALS, INC. Director Sell 5.0 -15,000 -93.75% ✓ $2.6M
Dec 18, 2020 Dec 22, 2020 ALNYLAM PHARMACEUTICALS, INC. Director Sell 5.0 -15,000 -93.75% ✓ $2.1M
Feb 10, 2020 Feb 11, 2020 ALNYLAM PHARMACEUTICALS, INC. Director Sell 5.0 -30,000 -96.77% ✓ $3.9M
Jan 14, 2016 Jan 15, 2016 Voyager Therapeutics, Inc. CEO Buy 82.5 +10,000 1.16% ✗ $140.7K
Jan 26, 2015 Jan 28, 2015 ALNYLAM PHARMACEUTICALS, INC. Director Buy 95.0 +1,000 100.00% ✗ $95K